BioDuro-Sundia Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Private

  • Employees
  • 3,000

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 3

  • Investments
  • 6

BioDuro-Sundia General Information

Description

Operator of a contract research development amd manufacturing organization (CRDMO) intended for commercial drug products. The company offers fully integrated services to support its efforts from target identification to commercial drug product manufacturing, enabling biotech and pharmaceutical partners to deliver their drugs to patients and improve their lives.

Contact Information

Website
www.bioduro.com
Formerly Known As
BioDuro
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 9601 Jeronimo Road
  • Irvine, CA 92618
  • United States
+1 (949)
Primary Industry
BPO/Outsource Services
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Corporate Office
  • 9601 Jeronimo Road
  • Irvine, CA 92618
  • United States
+1 (949)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioDuro-Sundia Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BioDuro-Sundia‘s full profile, request access.

Request a free trial

BioDuro-Sundia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a contract research development amd manufacturing organization (CRDMO) intended for commercial drug products
BPO/Outsource Services
Irvine, CA
3,000 As of 2026

London, United Kingdom
 

Toledo, OH
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioDuro-Sundia Competitors (66)

One of BioDuro-Sundia’s 66 competitors is NextPharma, a Private Equity-Backed company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NextPharma Private Equity-Backed London, United Kingdom
North American Science Associates Private Equity-Backed Toledo, OH
Theorem Clinical Research Formerly PE-Backed King of Prussia, PA
Bend Bioscience (Formerly CoreRx) Private Equity-Backed Clearwater, FL
Anthem Biosciences Formerly PE-Backed Bengaluru, India
You’re viewing 5 of 66 competitors. Get the full list »

BioDuro-Sundia Patents

BioDuro-Sundia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230167132-A1 Forms and compositions of inhibitors of plasma kallikrein Inactive 17-Apr-2020
US-11370803-B2 Heteroaryl plasma kallikrein inhibitors Active 18-Sep-2019
US-12065448-B2 Heteroaryl plasma kallikrein inhibitors Active 18-Sep-2019
US-20210079022-A1 Heteroaryl plasma kallikrein inhibitors Active 18-Sep-2019
US-20220298176-A1 Heteroaryl plasma kallikrein inhibitors Active 18-Sep-2019 C07D519/00
To view BioDuro-Sundia’s complete patent history, request access »

BioDuro-Sundia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioDuro-Sundia Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BioDuro-Sundia‘s full profile, request access.

Request a free trial

BioDuro-Sundia Investments (6)

BioDuro-Sundia’s most recent deal was a Joint Venture with Joint Venture (Chunghwa Chemical Synthesis & Biotech Company / BioDuro-Sundia). The deal was made on 03-Mar-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Joint Venture (Chunghwa Chemical Synthesis & Biotech Company / BioDuro-Sundia) 03-Mar-2026 Joint Venture Drug Discovery
Commercial Drug Product Manufacturing Facility ( 45,000 ft2 ) 01-Jan-2022 Buyout/LBO Buildings and Property
BioDuro-Sundia (Commercial Drug Product Manufacturing Facility in Irvine, California) 23-Aug-2021 Buyout/LBO Buildings and Property
Sundia MediTech 24-Sep-2020 Buyout/LBO BPO/Outsource Services
Molecular Response 05-Mar-2018 Buyout/LBO Biotechnology
You’re viewing 5 of 6 investments. Get the full list »

BioDuro-Sundia Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Molecular Response San Diego, CA 2010

BioDuro-Sundia FAQs

  • When was BioDuro-Sundia founded?

    BioDuro-Sundia was founded in 1996.

  • Where is BioDuro-Sundia headquartered?

    BioDuro-Sundia is headquartered in Irvine, CA.

  • What is the size of BioDuro-Sundia?

    BioDuro-Sundia has 3,000 total employees.

  • What industry is BioDuro-Sundia in?

    BioDuro-Sundia’s primary industry is BPO/Outsource Services.

  • Is BioDuro-Sundia a private or public company?

    BioDuro-Sundia is a Private company.

  • What is BioDuro-Sundia’s current revenue?

    The current revenue for BioDuro-Sundia is .

  • Who are BioDuro-Sundia’s investors?

    Advent International and Bridgewest Group have invested in BioDuro-Sundia.

  • Who are BioDuro-Sundia’s competitors?

    NextPharma, North American Science Associates, Theorem Clinical Research, Bend Bioscience (Formerly CoreRx), and Anthem Biosciences are some of the 66 competitors of BioDuro-Sundia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process